Review Article
Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer
Figure 5
Phenome-centered multiomics studies in ovarian cancers. The center of multiomics is being moved from genomics to phenomics, especially proteomics and metabolomics. Modified from Zhan et al. [189], with permission from Elsevier publisher, copyright 2018, and reproduced from Li et al. [62], with permission from Wiley publisher, copyright 2021.